EBNEO Commentary: Dexamethasone Eye Drops to Prevent Treatment-Requiring Retinopathy of Prematurity: The DROPROP Randomised Clinical Trial.
文献摘要
Topical dexamethasone showed a promising but statistically inconclusive reduction in treatment-requiring ROP (20% vs. 38%; adjusted OR 0.44; 95% CI 0.17-1.12; p = 0.08).